Product
RC1012 injection
1 clinical trial
1 indication
Indication
Acute Myeloid LeukemiaClinical trial
A Phase I/II Clinical Trial of RC1012 Injection for the Prevention of Relapse in AML Patients After Allogeneic Hematopoietic Stem Cell TransplantationStatus: Recruiting, Estimated PCD: 2024-05-27